Independent Equity Research Coverage Initiated by Bowsprit Partners
London, United Kingdom – 30 June, 2026 - Rapid Nutrition PLC (Euronext Growth Paris: ALRPD) is pleased to advise that Bowsprit Partners has initiated independent equity research coverage of the Company. The research report has also been made available to investors via the Company's Investor Relations website under the Independent Research Coverage section.
Independent Research Disclaimer
The research report has been prepared independently by Bowsprit Partners and represents solely the views, opinions, forecasts and conclusions of the author. The report should not be construed as recommendations, endorsements or opinions of Rapid Nutrition PLC or its directors, officers, employees or advisers.
Investors are encouraged to read the full report, including all disclaimers, disclosures and risk warnings contained therein, before making any investment decision.
The report can be accessed via the Company's Investor Relations website under the Research Coverage section.
About Rapid Nutrition
Rapid Nutrition PLC is a global HealthTech company advancing wellness through evidence-based, personalized nutrition solutions. By leveraging artificial intelligence, advanced technologies, and clinical research, the company delivers products and programs designed to optimize nutrition, improve health outcomes, and promote sustainable, healthier lifestyles worldwide.
Investor Relations Contact:
ir@rnplc.com
Investor Access (24/7 AI Platform)
+1 (855) 77-ALRPD
Disclaimer
This announcement contains forward-looking statements, including statements regarding the Company’s expectations, intentions, plans, beliefs or forecasts. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or developments to differ materially from those expressed or implied by such statements. These forward-looking statements are based on assumptions and assessments made by the Company in light of its experience and perception of historical trends, current conditions and expected future developments. Forward-looking statements speak only as at the date of this announcement.
Except as required by applicable law or regulation, Rapid Nutrition PLC undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are provided for illustrative purposes only and are not guarantees of future performance.
This announcement is for information purposes only and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities of Rapid Nutrition PLC in any jurisdiction. This announcement does not constitute a prospectus, offering memorandum or admission document for the purposes of the UK prospectus regime, Regulation (EU) 2017/1129 (the “Prospectus Regulation”), the U.S. Securities Act of 1933 (as amended), or the rules of any securities exchange or trading venue.
The distribution of this announcement may be restricted by law in certain jurisdictions. Persons into whose possession this announcement comes are required to inform themselves about, and to observe, any such restrictions. Any failure to comply with such restrictions may constitute a violation of applicable securities laws.